Upregulation in Bcl2 and other anti-apoptotic proteins is also observed, in patients who have progressed to LBC or MBC stages (Fig. 4; 21 matched samples). The gene discussed is BCL2; the disease is CDH1-related diffuse gastric and lobular breast cancer syndrome.